首页> 外文期刊>DMW: Deutsche Medizinische Wochenschrift >A very rare cause of haemoptysis - Coexistence of primary oncocytic adenoma of trachea with bronchial carcinoma [Eine ?uβerst seltene Ursache von H?moptysen: Koexistenz eines prim?ren onkozyt?ren Adenoms der Trachea und eines Adenokarzinoms des linken Oberlappens]
【24h】

A very rare cause of haemoptysis - Coexistence of primary oncocytic adenoma of trachea with bronchial carcinoma [Eine ?uβerst seltene Ursache von H?moptysen: Koexistenz eines prim?ren onkozyt?ren Adenoms der Trachea und eines Adenokarzinoms des linken Oberlappens]

机译:咯血的一种非常罕见的原因-气管原发性囊性腺瘤与支气管癌并存。

获取原文
获取原文并翻译 | 示例
           

摘要

History and admission findings: A 70-year-old man with a past history of COPD stage GOLD D with home oxygen therapy and tracheotomy due to long-term ventilation (898 hours) 6 years ago was admitted for investigation of haemoptysis during oral anticoagulation. He suffered from peripheral arterial disease (PAD) with bypass and repeated thrombectomy due to recurrent bypass caps, despite effective warfarin therapy. He had all cardiovascular risk factors. Investigations: The suspicion of a bronchial carcinoma was confirmed by CT. Bronchoscopically a 2cm lesion in the left upper lobe was biopsied. Additionally, bronchoscopy revealed an approximately erythematous, bloody discolored lesion (diameter 7mm) at a tracheotomy scar. Diagnosis, treatment and course: The biopsies revealed an adenocarcinoma in the left upper lobe and an oncocytic adenoma of the trachea - an extremely rare adenoma. The staging result was cT1b cN0 cM0 G2 IASLC Ia. Because of his severe multiple diseases the patient was in an inoperable condition. An interdisciplinary tumor conference recommended an individualized approach with a definitive radiotherapy of the adenocarcinoma. Endoscopic control of the macroscopically completely removed oncocytic adenoma of the trachea shall be performed one year later. Conclusions: Oncocytoma is an extremely rare adenoma (of the trachea), which in this case, has caused haemoptysis in addition to lung cancer during anticoagulation. For tumor genesis a reactive or hyperplasic response after tracheotomy 6 years ago is considered. Resection is the treatment of choice because of the potential for infiltrative growth. But the decision to treat always depends on individual benefit.
机译:病史和入院发现:6年前,一名70岁的男性,曾因长期通气(898小时)因长期通气(898小时)因家庭放氧和气管切开术而在COPD阶段GOLD D的既往史中被接受接受口服抗凝治疗期间的咯血研究。尽管有有效的华法林疗法,但由于反复的旁路帽,他仍患有旁路旁路的外周动脉疾病(PAD)和反复的血栓切除术。他有所有心血管危险因素。研究:CT证实怀疑是支气管癌。支气管镜检查左上叶2cm病变。另外,支气管镜检查发现在气管切开术疤痕处出现了大约红斑,血性变色的病变(直径7mm)。诊断,治疗和过程:活检显示左上叶有腺癌和气管的囊性腺瘤-一种极为罕见的腺瘤。分期结果为cT1b cN0 cM0 G2 IASLC Ia。由于他患有多种疾病,患者处于无法手术的状态。一个跨学科的肿瘤会议推荐了一种针对腺癌的明确放疗的个性化方法。一年后应进行内窥镜控制,从宏观上完全去除气管的囊性腺瘤。结论:肿瘤细胞瘤是一种非常罕见的(气管的)腺瘤,在这种情况下,在抗凝治疗期间,除肺癌以外,它还引起了咯血。对于肿瘤的发生,考虑6年前气管切开术后的反应性或增生性反应。切除是治疗的选择,因为它具有浸润性生长的潜力。但是,治疗的决定始终取决于个人利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号